Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)

Clinical trial NCT06255210 · RECRUITING

Trial details

NCT number: NCT06255210
Sponsor: Hongmeng Yu
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Olfactory Neuroblastoma

Start date: 2024-03-01
Primary completion: 2027-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.